Patent ID: 11859256
Assignee: NATIONAL CANCER CENTER
Field: Measurement (Instruments)
Classification: CPC C  G | IPC C  G

Claim 0:
1. A method for detecting stomach cancer in a human subject, comprising:
measuring an expression level of hsa-miR-718 in a blood, serum or plasma sample from the subject;
comparing the measured expression level of hsa-miR-718 to a control expression level for a healthy subject;
detecting an increased level of hsa-miR-718 in the sample from the subject as compared to the control expression level from the sample from the healthy subject;
wherein the increased level of hsa-miR-718 indicates that the subject has stomach cancer; and
wherein the method further comprises treating the subject for the stomach cancer or performing a diagnostic procedure on the subject with the stomach cancer;
wherein the treating comprises surgery, radiotherapy, chemotherapy or a combination thereof; and
wherein the diagnostic procedure comprises gastric X-ray examination, gastroscopy, or imaging of the stomach.